CEPI partners with Intravacc to develop an intranasal, broadly protective Betacoronavirus vaccine
CEPI partners with Intravacc to develop an intranasal, broadly protective Betacoronavirus vaccinee Bilthoven, The Netherlands, 6 October 2022 – CEPI, the Coalition for Epidemic Preparedness Innovations, and Dutch vaccine clinical development and manufacturing organization Intravacc, today announced the latest funding award under CEPI’s US$200m programme to advance the development of vaccines that provide broad protection against SARS-CoV-2…
